Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMPR1B | O00238 | 1/20 | 0.55 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.51 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.51 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20483308 | 0.92 | LMNA (0.60) | ADORA1ADORA3LMNAALDH1A1GLA | |
| SCHEMBL11992626 | 0.92 | BMPR1B (0.62) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL17014896 | 0.92 | BMPR1B (0.62) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL26347621 | 0.92 | BMPR1B (0.62) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL25496185 | 0.89 | BMPR1B (0.53) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL26297894 | 0.89 | BMPR1B (0.53) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL29313494 | 0.89 | BMPR1B (0.56) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL25765124 | 0.88 | MEN1 (0.54) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL26553799 | 0.88 | MEN1 (0.54) | BMPR1BP2RY12P2RY2P2RY1P2RY6 | |
| SCHEMBL22930668 | 0.86 | PRMT6 (0.52) | BMPR1BP2RY12P2RY2P2RY1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036231-B2 | Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036231-B2 | Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling | STING1, IRF3, CGAS | BMPR1B 3245/4885P2RY12 203/4885P2RY2 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.